These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 9694470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
    Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley SA.
    Ann Surg; 1998 Apr; 227(4):513-8. PubMed ID: 9563539
    [Abstract] [Full Text] [Related]

  • 4. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T, Mahidol C, Chun-On P, Laohapand C, Siripongsakun S, Worakitsitisatorn A, Vidhayakorn S, Boonchuay W, Dechma J, Sornsamdang G, Soonklang K, Sriprayoon T, Tanwandee T, Auewarakul CU.
    World J Gastroenterol; 2016 Sep 14; 22(34):7806-12. PubMed ID: 27678364
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
    Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB.
    Am J Gastroenterol; 2003 Mar 14; 98(3):679-90. PubMed ID: 12650806
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
    Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M.
    Gut; 2001 Feb 14; 48(2):251-9. PubMed ID: 11156649
    [Abstract] [Full Text] [Related]

  • 9. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
    Bolondi L, Gaiani S, Casali A, Serra C, Piscaglia F.
    Radiol Med; 1997 Feb 14; 94(1-2):4-7. PubMed ID: 9424649
    [Abstract] [Full Text] [Related]

  • 10. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N, Chaffaut C, Bourcier V, Archambeaud I, Perarnau JM, Oberti F, Roulot D, Moreno C, Louvet A, Dao T, Moirand R, Goria O, Nguyen-Khac E, Carbonell N, Antonini T, Pol S, de Ledinghen V, Ozenne V, Henrion J, Péron JM, Tran A, Perlemuter G, Amiot X, Zarski JP, Beaugrand M, Chevret S, for CIRRAL Group.
    J Hepatol; 2018 Dec 14; 69(6):1274-1283. PubMed ID: 30092234
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D.
    Z Gastroenterol; 1997 Dec 14; 35(12):1059-67. PubMed ID: 9487638
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
    Mok TS, Yu SC, Lee C, Sung J, Leung N, Lai P, Leung TW, Chan AT, Yeo W, Koh J, Johnson P.
    AJR Am J Roentgenol; 2004 Aug 14; 183(2):453-8. PubMed ID: 15269040
    [Abstract] [Full Text] [Related]

  • 15. Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C.
    Gavilán JC, Ojeda G, Arnedo R, Puerta S.
    Eur J Intern Med; 2013 Dec 14; 24(8):846-51. PubMed ID: 23849588
    [Abstract] [Full Text] [Related]

  • 16. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients.
    Sangmala P, Chaikledkaew U, Tanwandee T, Pongchareonsuk P.
    Asian Pac J Cancer Prev; 2014 Dec 14; 15(20):8993-9004. PubMed ID: 25374242
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 14; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
    Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, Del Ninno E, Colombo M.
    Hepatology; 1999 Jun 14; 29(6):1704-7. PubMed ID: 10347111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.